Sono-activatable engineered bacteria for antitumor therapy.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 38776871.
- Also identified by DOI 10.1016/j.xcrm.2024.101562 and PMC identifier 11148798.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bacteria show promising potential in tumor treatment, but safety concerns limit their application. In this issue, Gao et al.<sup>1</sup> develop ultrasound-controlled engineered bacteria through integrating sono-activatable gene circuits, achieving local production and release of therapeutic cargos in tumor.
Medical subject headings
- Neoplasms